Vanda Pharmaceuticals Announces Presentation at 2025 ASCP Annual Meeting
Provided By PR Newswire
Last update: May 27, 2025
WASHINGTON, May 27, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced participation at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting, to be held in Scottsdale, Arizona, from May 27 through May 30, 2025.
Read more at prnewswire.com
